NEW YORK (GenomeWeb News) – Thermo Fisher Scientific and the Technical University of Denmark's Department of System Biology today announced a collaboration to elucidate the process by which protein networks drive diseases.

Under the collaboration, a new proteomics laboratory will be established in Lyngby, Denmark equipped with Thermo Fisher LC-MS technology, including the Orbitrap Fusion Tribrid LC-MS platform, as well as four Q Exactive LC-MS/MS systems and nano-LC 1000 systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.